Obesity / breast neoplasms

Small molecules for treating breast cancer

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

BACKGROUND Approximately 70% of newly diagnosed breast cancer patients are estrogen receptor-.alpha. positive (ER+). However, almost 50% of all ER+ breast tumors will not respond to endocrine therapy. Tamoxifen produces an overall 26% proportional reduction in mortality but many ER+ tumors that show

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity. BACKGROUND OF THE INVENTION The estrogen

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity. BACKGROUND OF THE INVENTION The estrogen

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity. BACKGROUND OF THE INVENTION The estrogen

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity. BACKGROUND OF THE INVENTION The estrogen

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, including pharmaceutical compositions and uses thereof, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity. BACKGROUND OF THE INVENTION The estrogen

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, and to compounds for inhibiting cytokines, as well as to pharmaceutical compositions and methods related thereto. BACKGROUND OF THE INVENTION The estrogen hormone has a broad spectrum of effects on tissues in

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, and to compounds for inhibiting cytokines, as well as to pharmaceutical compositions and methods related thereto. BACKGROUND OF THE INVENTION The estrogen hormone has a broad spectrum of effects on tissues in

Organic compounds

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

Organic compounds

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

Organic compounds

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

Compounds and methods for modulation of estrogen receptors

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

TECHNICAL FIELD This invention is generally directed to estrogen antagonists and agonists, and to compounds for inhibiting cytokines, and more specifically to compounds which selectively modulate estrogen receptor-beta (ER-.beta.) activity, as well as to pharmaceutical compositions and methods

Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

FIELD OF THE INVENTION The present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and for treating conditions such as cancer, arthritis, inflammatory airway disease, and metabolic disorders. More particularly, the

Human cachexia associated protein

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

FIELD OF THE INVENTION The present invention is in the field of molecular biology; more particularly, the present invention describes the nucleic acid and amino acid sequences of a human, cachexia-associated protein. BACKGROUND OF THE INVENTION The characteristic wasting anorexia associated with

LKB1-AMPK activators for therapeutic use in polycystic kidney disease

Bare registrerte brukere kan oversette artikler

Logg inn Registrer deg

BACKGROUND Autosomal dominant polycystic kidney disease (ADPKD) is a frequently inherited kidney disorder with a gene frequency of 1 in 500 to 1,000 births affecting nearly 600,000 Americans and as many as 12 million people worldwide. This potentially lethal genetic disease is characterized by the

obesity/breast neoplasms

Small molecules for treating breast cancer

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Compounds and methods for modulation of estrogen receptors

Organic compounds

Organic compounds

Organic compounds

Compounds and methods for modulation of estrogen receptors

Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators

Human cachexia associated protein

LKB1-AMPK activators for therapeutic use in polycystic kidney disease

Den mest komplette databasen med medisinske urter støttet av vitenskap